Free Trial

Moolec Science Q2 2024 Earnings Report

Moolec Science logo
$0.56 0.00 (0.00%)
As of 03:56 PM Eastern

Moolec Science EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.05
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Moolec Science Revenue Results

Actual Revenue
$0.25 million
Expected Revenue
$0.63 million
Beat/Miss
Missed by -$380.00 thousand
YoY Revenue Growth
N/A

Moolec Science Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

Moolec Science Earnings Headlines

Moolec Science (NASDAQ:MLEC) Trading Up 5% - Here's Why
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical.
Moolec Science Appeals Nasdaq Delisting Notice
See More Moolec Science Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Moolec Science? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moolec Science and other key companies, straight to your email.

About Moolec Science

Moolec Science (NASDAQ:MLEC), a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

View Moolec Science Profile

More Earnings Resources from MarketBeat